UPADACITINIB AS SECOND- AND THIRD-LINE SALVAGE THERAPY FOR REFRACTORY ACUTE SEVERE ULCERATIVE COLITIS
2024 · Gastroenterology · 4 citations
https://doi.org/10.1053/j.gastro.2023.11.281
C
Courtney Perry
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
101
Papers
745
Citations
11
h-index
13
i10-index
Courtney Perry is an academic researcher. The author has contributed to research in topics: Inflammatory Bowel Disease & Microscopic Colitis & Obesity, Physical Activity, Diet. The author has an h-index of 11, co-authored 86 publications.
ORCID: 0000-0001-6177-3128Papers by this author
worksTu1828 EFFECTIVENESS OF UPADACITINIB FOR PATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS: A CASE-CONTROL STUDY
2024 · Gastroenterology · 0 citations
https://doi.org/10.1016/s0016-5085(24)03729-6
Choosing a drug to treat motion sickness
2025 · JAAPA · 0 citations
https://doi.org/10.1097/01.jaa.0000000000000097
Predicting self-administered biologic nonadherence in Medicare fee-for-service beneficiaries with inflammatory bowel disease using machine learning models
2025 · Journal of Managed Care & Specialty Pharmacy · 0 citations
https://doi.org/10.18553/jmcp.2026.32.1.27
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat